Cite
HARVARD Citation
Takeuchi, T. et al. (2016). Efficacy and safety of the oral Janus kinase inhibitor peficitinib (ASP015K) monotherapy in patients with moderate to severe rheumatoid arthritis in Japan: a 12-week, randomised, double-blind, placebo-controlled phase IIb study. Annals of the rheumatic diseases. 75 (6), pp. 1057-1064. [Online].